Aegros
Aegros is an Australian biotechnology and biopharmaceutical company based in Macquarie Park, New South Wales. The company specializes in producing therapeutic plasma-derived medicinal products through its proprietary HaemafracĀ® technology. Aegros is dedicated to improving patient access to life-saving plasma therapies and aims to lead the market by integrating its multi-patent pending CyMES technology with existing manufacturing processes. The company manufactures a range of products, including hyperimmune immunoglobulins, which are highly purified antibodies used to combat infections and modulate immune function. Aegros operates a TGA GMP-approved plasma fractionation facility in Sydney, which is expanding to process 100,000 liters of plasma annually. Aegros collaborates with governments, health systems, and patient groups to ensure reliable access to its plasma-derived medicines, emphasizing that access to these critical drugs is a human right.
Work at Aegros in HR or recruiting? Claim this page
Headcount trend
Aegros went from 68 employees in Oct 2024 to 59 in Sep 2026. Apr to Sep 2026: 7 people joined, 2 left.
Org structure
Headcount by department
Peer reviews
Worked with someone at Aegros?
Anonymous peer reviews on OffTheRecord
Similar companies
Aegros FAQ
How many employees does Aegros have?
Aegros has about 59 employees, up 3.5% over the 3 months to Sep 2026.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.